Showing 1 posts of 1 posts found.
Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO